{
  "emaEpar": [],
  "fdaDrugLabel": [],
  "id": "Talaporfin_Sodium",
  "nciThesaurus": {
    "casRegistry": "220201-34-3",
    "chebiId": "",
    "chemicalFormula": "C38H37N5O9.4Na",
    "definition": "An agent consisting of chlorin e6, derived from chlorophyll, and L-aspartic acid with photosensitizing activity.  After intratumoral activation by light emitting diodes, taporfin sodium forms an extended high energy conformational state that generates singlet oxygen, resulting in free radical-mediated cell death.",
    "fdaUniiCode": "L63605PZ70",
    "identifier": "C26675",
    "preferredName": "Talaporfin Sodium",
    "semanticType": "Pharmacologic Substance",
    "subclassOf": [
      "C1420"
    ],
    "synonyms": [
      "LS11",
      "Laserphyrin",
      "ME2906",
      "Mono-L-aspartyl Chlorin e6",
      "NPe6",
      "TALAPORFIN SODIUM",
      "Talaporfin Sodium",
      "Taporfin Sodium",
      "talaporfin sodium"
    ]
  }
}